Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$3.92B |
| 2 |
Visa
V
|
+$551M |
| 3 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$406M |
| 4 |
UnitedHealth
UNH
|
+$395M |
| 5 |
Advanced Micro Devices
AMD
|
+$363M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.41B |
| 2 |
NVIDIA
NVDA
|
+$2.28B |
| 3 |
Microsoft
MSFT
|
+$2.02B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.83B |
| 5 |
Flutter Entertainment
FLUT
|
+$962M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Consumer Discretionary | 7.14% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 4.81% |
| 5 | Communication Services | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Mayville Engineering Co
MEC
$661M
| $600K | ﹤0.01% |
38,143
+657
| +2% | +$12K |
|
3627
Tyra Biosciences
TYRA
$1.91B
| $599K | ﹤0.01% |
43,070
+5,445
| +14% | +$98.8K |
|
3628
CALL
Array Technologies
ARRY
$848M
| $599K | ﹤0.01% |
+99,100
| New | +$632K |
|
3629
PUT
Dow Inc
DOW
$21.9B
| $598K | ﹤0.01% |
14,900
-23,300
| -61% | -$1.09M |
|
3630
Aura Biosciences
AURA
$713M
| $598K | ﹤0.01% |
72,725
+11,715
| +19% | +$110K |
|
3631
Kodak
KODK
$822M
| $598K | ﹤0.01% |
90,970
+11,876
| +15% | +$67.5K |
|
3632
Pagaya Technologies
PGY
$1.83B
| $596K | ﹤0.01% |
+64,106
| New | +$677K |
|
3633
iShares MSCI Australia ETF
EWA
$1.4B
| $595K | ﹤0.01% |
24,955
-87,491
| -78% | -$2.25M |
|
|
YMAB
3634
DELISTED
Y-mAbs Therapeutics
YMAB
| $594K | ﹤0.01% |
75,862
+6,640
| +10% | +$80.9K |
|
3635
Direxion Daily Technology Bull 3x ETF
TECL
$5.31B
| $593K | ﹤0.01% |
6,550
-795
| -11% | -$74.1K |
|
3636
Centuri Holdings
CTRI
$2.84B
| $593K | ﹤0.01% |
30,690
+7,033
| +30% | +$137K |
|
3637
Ranger Energy Services
RNGR
$377M
| $589K | ﹤0.01% |
38,045
+4,641
| +14% | +$66.5K |
|
3638
Paymentus
PAY
$4.46B
| $588K | ﹤0.01% |
18,012
+12,954
| +256% | +$385K |
|
|
EBTC
3639
DELISTED
Enterprise Bancorp
EBTC
| $588K | ﹤0.01% |
14,880
-7,956
| -35% | -$286K |
|
3640
NRC Health Common Stock
NRC
$442M
| $588K | ﹤0.01% |
33,349
-17,982
| -35% | -$341K |
|
3641
Taysha Gene Therapies
TSHA
$1.65B
| $587K | ﹤0.01% |
335,238
+87,958
| +36% | +$182K |
|
3642
4D Molecular Therapeutics
FDMT
$519M
| $586K | ﹤0.01% |
105,245
-9,603
| -8% | -$75.4K |
|
|
GAMB
3643
DELISTED
Gambling.com
GAMB
| $585K | ﹤0.01% |
41,565
+3,071
| +8% | +$36.1K |
|
3644
Domo
DOMO
$176M
| $585K | ﹤0.01% |
82,573
+2,962
| +4% | +$24K |
|
3645
OmniAb
OABI
$284M
| $582K | ﹤0.01% |
164,315
+21,100
| +15% | +$83.5K |
|
3646
Greenlight Captial
GLRE
$549M
| $581K | ﹤0.01% |
41,529
+5,452
| +15% | +$77.4K |
|
3647
Frontier Group Holdings
ULCC
$1.73B
| $581K | ﹤0.01% |
81,710
+8,844
| +12% | +$55.2K |
|
|
ZIMV
3648
DELISTED
ZimVie
ZIMV
| $580K | ﹤0.01% |
41,602
-1,835
| -4% | -$26.3K |
|
|
ATYR
3649
aTyr Pharma
ATYR
$48M
| $577K | ﹤0.01% |
+159,407
| New | +$483K |
|
|
KALV
3650
DELISTED
KalVista Pharmaceuticals
KALV
| $576K | ﹤0.01% |
68,062
+840
| +1% | +$8.7K |
|
Similar funds
Barclays's Q4 2024 Portfolio in Review
As of Q4 2024, Barclays held 5,604 positions worth $357B, down 5.3% from $377B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays withdrew a net $28.7B in Q4 2024, closing 348 positions and reducing 1,552 holdings. Its most notable exit was Stericycle Inc, an estimated $97.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Barclays opened a new position in iShares Bitcoin Trust worth $131M.
- Barclays's largest Q4 2024 buy was iShares Bitcoin Trust: 2,473,064 shares worth $131M.
- Barclays added most to Honeywell in Q4 2024, an estimated $3.92B increase.
- Barclays's biggest Q4 2024 reduction was Apple, cutting an estimated $4.41B.
- Barclays fully exited Stericycle Inc in Q4 2024, selling an estimated $97.3M.
- Barclays's ten largest holdings make up 41% of its $357B portfolio in Q4 2024.
- Barclays opened 343 new positions and closed 348 in Q4 2024.
- Barclays's portfolio value fell 5.3% quarter-over-quarter to $357B.
Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.